| Brand name | Nonproprietary Name | Authorization date | Marketing authorisation holder |
|---|---|---|---|
| Abasaglar (previously Abasria) | insulin glargine | 2014-09-09 | Eli Lilly Regional Operations GmbH |
| Abilify | aripiprazole | 2004-06-04 | Otsuka Pharmaceutical Europe Ltd |
| Abilify Maintena | aripiprazole | 2013-11-15 | Otsuka Pharmaceutical Europe Ltd |
| Ablavar (previously Vasovist) | gadofosveset trisodium | 2005-10-03 | TMC Pharma Services Ltd. |
| Abraxane | paclitaxel | 2008-01-11 | Celgene Europe Ltd ? |
| Abseamed | epoetin alfa | 2007-08-28 | Medice Arzneimittel Pütter GmbH & Co. KG |
| Accofil | filgrastim | 2014-09-18 | Accord Healthcare Ltd |
| Aclasta | zoledronic acid | 2005-04-15 | Novartis Europharm Limited |
| Acomplia | rimonabant | 2006-06-19 | sanofi-aventis |
| Acrescent | memantine hydrochloride / donepezil hydrochloride | 2013-02-20 | H. Lundbeck A/S |
| Actelsar HCT | telmisartan / hydrochlorothiazide | 2013-03-13 | Actavis Group hf |
| Actos | pioglitazone | 2000-10-13 | Takeda Pharma A/S |
| Actraphane | insulin human (rDNA) | 2002-10-07 | Novo Nordisk A/S |
| Actrapid | human insulin(rDNA) | 2002-10-07 | Novo Nordisk A/S |
| Adasuve | loxapine | 2013-02-20 | Ferrer Internacional s.a. |
| Adcetris | brentuximab vedotin | 2012-10-25 | Takeda Pharma A/S |
| Adcirca (previously Tadalafil Lilly) | tadalafil | 2008-10-01 | Eli Lilly Nederland B.V. |
| Adempas | riociguat | 2014-03-27 | Bayer Pharma AG |
| Adenuric | febuxostat | 2008-04-21 | Menarini International Operations Luxembourg S.A. (MIOL) |
| Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) | pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) | 2009-10-10 | GlaxoSmithKline Biologicals S.A. |